- Nachrichtendetail
-
16.05.2024 13:48:21 - dpa-AFX: *LILLY : PHASE 3 TRIALS OF ONCE-WEEKLY INSULIN IN TYPE 2 DIABETES MEETS PRIMARY ENDPOINT
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Eli Lilly & Co | 858560 | NYSE | 878,450 | 14.06.24 03:00:19 | -4,880 | -0,55% | 878,700 | 888,000 | 882,330 | 878,450 |
